3SBio's (HKG:1530) attributable net profit declined 15.6% to 1.15 billion yuan in the first half from 1.36 billion yuan a year ago, according to a Thursday filing with the Hong Kong Exchange.
Earnings per share fell to 0.44 yuan from 0.56 yuan a year earlier, the biopharmaceutical company said.
Revenue in the six months ended June 30 rose 3.9% to 4.53 billion yuan from 4.36 billion yuan.